Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Statins may help treat alopecia areata by reducing harmful immune interactions.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Hair cortisol levels peak in the third trimester and decline postpartum.

Hair gels may cause split ends in children.

Cannabinoids may help some skin conditions but more research is needed.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.